LAKESHORE BIOPHARMA CO LTD (LSB)
KYG9845F1090 - Common Stock
LAKESHORE BIOPHARMA CO LTD
NASDAQ:LSB (12/20/2024, 8:22:55 PM)
After market: 3 +0.04 (+1.35%)2.96
+0.26 (+9.63%)
Company Profile
LakeShore Biopharma Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 758 full-time employees. The company went IPO on 2021-07-30. LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The firm's vaccine product YSJATM rabies vaccine has been commercialized. The firm also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Company Info
LAKESHORE BIOPHARMA CO LTD
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park
Beijing BEIJING
P: 17327133678
Employees: 758
Website: https://www.ysbiopharm.com/
LSB News
2 days ago - LakeShore BiopharmaLakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance/PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
8 days ago - LakeShore Biopharma Co., LtdLakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China8 days ago - LakeShore Biopharma Co., LtdLakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in ChinaBEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a leading global...
a month ago - LakeShore Biopharma Co., LtdLakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan2 months ago - LakeShore Biopharma Co., LtdLakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement/PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to...
2 months ago - LakeShore Biopharma Co., Ltd.LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine/PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to...
LSB Twits
Here you can normally see the latest stock twits on LSB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
